Nevada
|
000-53166
|
77-0664193
|
(State or Other Jurisdiction
of incorporation)
|
(Commission File No.)
|
(I.R.S. Employer
Identification Number)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Exhibit
No.
|
Description
|
99.1
|
Resignation
Letter of Michael Shawn Wingate, dated as of December 21,
2010.
|
MUSCLEPHARM
CORPORATION
|
|||
Date:
December 22, 2010
|
By:
|
/s/ Brad
Pyatt
|
|
Brad
Pyatt
|
|||
Chief
Executive Officer
|